SUSQUEHANNA INTERNATIONAL GROUP, LLP CURE — DIREXION SHS ETF TR HEALTHCARE BUL

Ownership history in SUSQUEHANNA INTERNATIONAL GROUP, LLP  ·  147 quarters on record

AI Ownership Summary

SUSQUEHANNA INTERNATIONAL GROUP, LLP reported DIREXION SHS ETF TR HEALTHCARE BUL (CURE) in 147 quarterly 13F filings from 2024 Q1 through 2026 Q1. The latest visible filing shows CURE at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this CURE ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was SUSQUEHANNA INTERNATIONAL GROUP, LLP's position in DIREXION SHS ETF TR HEALTHCARE BUL, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

CURE was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2025 Q3

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q1 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

CURE stock page SUSQUEHANNA INTERNATIONAL GROUP, LLP fund profile SUSQUEHANNA INTERNATIONAL GROUP, LLP full holdings
How SUSQUEHANNA INTERNATIONAL GROUP, LLP held CURE — position size vs. price
% of Fund (quarterly)    CURE price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 26 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 REDUCED 79.1% +27.9% ❌ 14,032 -53,168 -79.1% 0.00% $1.3M 2026-05-15 $86.79
2026 Q1 ADDED — — — 67,200 +39,300 +140.9% 0.00% $6.2M 2026-05-15 $86.79
2026 Q1 ADDED — — — 27,900 +1,682 +6.4% 0.00% $2.6M 2026-05-15 $86.79
2025 Q4 REDUCED 24.7% -17.7% ✅ 26,218 -8,582 -24.7% 0.00% $2.9M 2026-02-17 $113.99
2025 Q4 REDUCED 42.4% -17.7% ✅ 34,800 -25,600 -42.4% 0.00% $3.9M 2026-02-17 $113.99
2025 Q4 ADDED — — — 60,400 +45,487 +305.0% 0.00% $6.7M 2026-02-17 $113.99
2025 Q3 REDUCED 94.0% +36.5% ❌ 14,913 -233,887 -94.0% 0.00% $1.2M 2025-11-14 $105.13
2025 Q3 ADDED — — — 248,800 +154,300 +163.3% 0.00% $20.8M 2025-11-14 $105.13
2025 Q3 ADDED — — — 94,500 +63,200 +201.9% 0.00% $7.9M 2025-11-14 $105.13
2025 Q2 REDUCED 22.1% -0.9% ✅ 31,300 -8,900 -22.1% 0.00% $2.5M 2025-08-14 $74.22
2025 Q2 ADDED — — — 40,200 +18,947 +89.1% 0.00% $3.2M 2025-08-14 $74.22
2025 Q1 ADDED — — — 21,253 +3,253 +18.1% 0.00% $2.3M 2025-05-14 $68.33
2025 Q1 REDUCED 57.0% -25.8% ✅ 18,000 -23,900 -57.0% 0.00% $1.9M 2025-05-14 $68.33
2025 Q1 ADDED — — — 41,900 +18,144 +76.4% 0.00% $4.5M 2025-05-14 $68.33
2024 Q4 ADDED — — — 23,756 +7,456 +45.7% 0.00% $2.2M 2025-02-14 $103.10
2024 Q4 REDUCED 19.3% +15.9% ❌ 16,300 -3,900 -19.3% 0.00% $1.5M 2025-02-14 $103.10
2024 Q4 REDUCED 51.5% +15.9% ❌ 20,200 -21,455 -51.5% 0.00% $1.9M 2025-02-14 $103.10
2024 Q3 ADDED — — — 41,655 +28,255 +210.9% 0.00% $5.5M 2024-11-14 $105.43
2024 Q3 ADDED — — — 13,400 +2,900 +27.6% 0.00% $1.8M 2024-11-14 $105.43
2024 Q3 REDUCED 50.3% -31.4% ✅ 10,500 -10,613 -50.3% 0.00% $1.4M 2024-11-14 $105.43
2024 Q2 REDUCED 6.6% +14.3% ❌ 21,113 -1,487 -6.6% 0.00% $2.5M 2024-08-15 $127.90
2024 Q2 ADDED — — — 22,600 +10,700 +89.9% 0.00% $2.6M 2024-08-15 $127.90
2024 Q2 REDUCED 69.5% +14.3% ❌ 11,900 -27,142 -69.5% 0.00% $1.4M 2024-08-15 $127.90
2024 Q1 ADDED — — — 39,042 +16,242 +71.2% 0.00% $4.9M 2024-05-07 $107.82
2024 Q1 ADDED — — — 22,800 +5,000 +28.1% 0.00% $2.9M 2024-05-07 $107.82
2024 Q1 REDUCED 46.9% -8.2% ✅ 17,800 -15,724 -46.9% 0.00% $2.2M 2024-05-07 $107.82
121 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding CURE

As of 2026 Q1 — sorted by position size

GTS SECURITIES LLC 0.04% Traynor Capital Management, Inc. 3Y 7Y 0.03% Onyx Bridge Wealth Group LLC 3Y 0.02% SBI Securities Co., Ltd. 0.02% Pinnacle Wealth Planning Services, Inc. 3Y 7Y 0.0% Summit Financial, LLC 3Y 7Y 0.0% Belvedere Trading LLC 3Y 7Y 0.0% Tower Research Capital LLC (TRC) 3Y 7Y 0.0% CITADEL ADVISORS LLC 3Y 7Y 0.0% OSAIC HOLDINGS, INC. 3Y 0.0%

FAQ About SUSQUEHANNA INTERNATIONAL GROUP, LLP and CURE

These are the practical questions this page is built to answer before you even open the full history table.

How long has SUSQUEHANNA INTERNATIONAL GROUP, LLP reported owning CURE?

SUSQUEHANNA INTERNATIONAL GROUP, LLP reported CURE across 26 quarterly 13F filings, from 2024 Q1 through 2026 Q1.

What was the largest reported CURE position in SUSQUEHANNA INTERNATIONAL GROUP, LLP's portfolio?

The largest reported portfolio weight for CURE was 0.00% in 2025 Q3.

What is the latest reported CURE position on this page?

The most recent filing on this page is 2026 Q1, when SUSQUEHANNA INTERNATIONAL GROUP, LLP reported 14,032 shares, equal to 0.00% of portfolio, with an estimated market value of $1.3M.

What does the chart on this CURE ownership page compare?

The chart compares SUSQUEHANNA INTERNATIONAL GROUP, LLP's quarterly CURE portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did SUSQUEHANNA INTERNATIONAL GROUP, LLP time their CURE position?

Based on 13F filing dates vs. subsequent CURE price moves, SUSQUEHANNA INTERNATIONAL GROUP, LLP correctly timed 78 out of 146 reported position changes (53%). The annualised alpha on CURE relative to SPY over the holding period was +8.1%.

← Back to SUSQUEHANNA INTERNATIONAL GROUP, LLP Holdings